CompletedNCT03746366
[C-11]PiB PET Imaging in Alcohol Use Disorders
Medication studyAges 40–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 40 years to 65 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: December 1, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 39
- Sponsor
- University of Pittsburgh
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug, RADIATION
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 40 Years to 65 Years
- Official registry ID
- NCT03746366
- Official title
Show the full official title
Imaging Beta-amyloid in Middle Age Alcoholics As a Mechanism That Increases Their Risk for Alzheimer's Disease
Get this study by email
Recruitment & locations
CompletedPittsburgh
Questions about this study
Who is behind this study?
The study sponsor is University of Pittsburgh, a university.
Did this study involve medication?
Yes. The study involved medication, including Pittsburgh Compound B.
Who was this study for?
Listed age limits: 40 years to 65 years.
